McMaster Nuclear Reactor

TRIUMF Innovations and the Centre for Probe Development and Commercialization to Receive up to $35 Million in Funding for their Canadian Medical Isotope Ecosystem

Retrieved on: 
Tuesday, June 27, 2023
Canadian Nuclear Laboratories Research Facilities, Commercialization, The Honourable, McMaster Nuclear Reactor, Cancer, Strategic Innovation Fund, Research, Radiopharmaceutical, Government, Investment, Economic development, Ecosystem, Health, Innovation, Science and Economic Development Canada, SME, TRIUMF, Pharmaceutical industry, Medical imaging, Science

The Canadian Medical Isotope Ecosystem will support the development, production, advancement and distribution of isotopes, and position Canada as an international medical isotope powerhouse

Key Points: 
  • Vancouver, British Columbia, and Hamilton, Ontario--(Newsfile Corp. - June 27, 2023) - TRIUMF Innovations and the Centre for Probe Development and Commercialization (CPDC) today announced they will receive up to $35 million in funding for the creation of the new Canadian Medical Isotope Ecosystem (CMIE).
  • Over the term of the funding, CMIE is expected to launch three high-demand medical isotopes and related drug products into the marketplace.
  • "Our government is proud to partner with CPDC and TRIUMF Innovations as part of our Biomanufacturing and Life Sciences Strategy to create the Canadian Medical Isotope Ecosystem.
  • With TRIUMF Innovations' focus on commercialization, we are pleased with this new level of support for medical isotope commercialization from Minister Champagne and the Canadian government."

Government of Canada teams up with Indigenous partners, Bruce Power and the medical isotope community to fight cancer

Retrieved on: 
Tuesday, June 27, 2023
SON, Canadian Nuclear Laboratories Research Facilities, Saugeen Ojibway Nation Territory, Partnership, Commercialization, Sickness, McMaster Nuclear Reactor, Marketing, Framatome, Chippewas of Nawash Unceded First Nation, Cancer, Saugeen First Nation, Research, Ytterbium, Parliament, Nuclear medicine, Bruce Power, Hon, Patient, Physician, Investment, Public security, Government of Canada, Ecosystem, Federation, Health, Isotope, Oakville North—Burlington, IPS, Safety, TRIUMF, Rare-earth element, Uranium mining, Medical imaging, Renewable energy, Pharmaceutical industry, Science, Isogenic human disease models, Ojibwe

The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.

Key Points: 
  • The partnership includes Indigenous communities, Ontario’s nuclear industry, and leading research facilities, academics, and firms working to commercialize novel therapies.
  • This funding will ultimately enable a pan-Canadian consortium – the Canadian Medical Isotope Ecosystem (CMIE) – to advance and accelerate the development of the next generation of novel medical isotopes and technologies.
  • “Canada is a world leader in medical isotope research and production, and Bruce Power is proud to be among the innovative companies that places Canada at the forefront of nuclear medicine,” said Mike Rencheck, Bruce Power’s President and CEO.
  • “Our government is proud to partner in the creation of the Canadian Medical Isotope Ecosystem, which includes support for the SON First Nations communities’ partnership with Bruce Power to innovate in the fight against cancer,” said Minister Champagne.

CNL and AECL Continue Pursuit of Closer Ties With Canada’s Academic Community Through MOU With McMaster University

Retrieved on: 
Tuesday, November 29, 2022
Graphite-moderated reactor, Atomic Energy of Canada Limited, Waste management, Environment, McMaster Nuclear Reactor, Laboratory, Organization, Engineering, Isotope, Private sector, Chalk River Laboratories, Vision 2030, Climate change, Environmental science, MOU, Patient, MNR, Government, McMaster, Science and technology, Workforce, National Nuclear Laboratory, Medicine, McMaster University, CANDU, Cancer, Health, Hydrogen, Research, Intellectual property, Neutron, Crown, Radiochemistry, AECL, Safety, CNL, Uranium, Renewable energy, Tourism, Science

CHALK RIVER, Ontario, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology laboratory, is pleased to announce that it has signed a Memorandum of Understanding (MOU) with Atomic Energy of Canada Limited (AECL), Canada’s nuclear Crown Corporation, and McMaster University to pursue collaborative research opportunities. The MOU represents continued progress for Canada’s national nuclear laboratories as it works to build closer ties with Canada’s academic community, and is the third agreement signed in recent weeks with a leading Canadian university that is designed to advance collaborative research in health and environmental sciences, clean energy and nuclear safety.

Key Points: 
  • That is the driving force behind CNLs ongoing outreach and engagement with the academic community, and we are thrilled to further grow our relationship with McMaster University as part of that effort.
  • This agreement is a key step on our path forward, said Amy Gottschling, AECL Vice President, Science, Technology and Commercial Oversight.
  • Together, CNL, AECL and McMaster operate some of the most unique and advanced nuclear facilities and research laboratories, not just in Canada, but around the world.
  • Located in Hamilton, Ontario, McMaster University is among Canadas most research-intensive universities, and the nations preeminent nuclear research institution.